Anika files preliminary proxy statement

Bedford, mass., march 27, 2023 (globe newswire) -- anika therapeutics, inc. (nasdaq: anik) (“anika” or the “company”), a global joint preservation company in early intervention orthopedics, today announced that it has filed its preliminary proxy materials with the securities and exchange commission (“sec”) in connection with its upcoming 2023 annual meeting of stockholders (the “annual meeting”). the meeting date has not yet been scheduled and shareholders do not need to take any action at this time.
ANIK Ratings Summary
ANIK Quant Ranking